These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 30899071)
21. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice. Han HS; Jun HS; Utsugi T; Yoon JW J Autoimmun; 1996 Jun; 9(3):331-9. PubMed ID: 8816968 [TBL] [Abstract][Full Text] [Related]
22. T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives. Mallone R; Brezar V; Boitard C Clin Dev Immunol; 2011; 2011():513210. PubMed ID: 21785617 [TBL] [Abstract][Full Text] [Related]
24. An HLA-Transgenic Mouse Model of Type 1 Diabetes That Incorporates the Reduced but Not Abolished Thymic Insulin Expression Seen in Patients. Babad J; Ali R; Schloss J; DiLorenzo TP J Diabetes Res; 2016; 2016():7959060. PubMed ID: 26824049 [TBL] [Abstract][Full Text] [Related]
25. Role of the first external domain of I-A beta chain in immune responses and diabetes in non-obese diabetic (NOD) mice. Singh B; Dillon T; Fraga E; Lauzon J J Autoimmun; 1990 Oct; 3(5):507-21. PubMed ID: 1701300 [TBL] [Abstract][Full Text] [Related]
26. Presence of residual beta cells and co-existing islet autoimmunity in the NOD mouse during longstanding diabetes: a combined histochemical and immunohistochemical study. Reddy S; Chai RC; Rodrigues JA; Hsu TH; Robinson E J Mol Histol; 2008 Feb; 39(1):25-36. PubMed ID: 17891462 [TBL] [Abstract][Full Text] [Related]
27. β-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD mice. Manzoor F; Johnson MC; Li C; Samulski RJ; Wang B; Tisch R Eur J Immunol; 2017 Jan; 47(1):144-154. PubMed ID: 27859048 [TBL] [Abstract][Full Text] [Related]
28. An antigen-specific immunotherapeutic, AKS-107, deletes insulin-specific B cells and prevents murine autoimmune diabetes. Alleva DG; Delpero AR; Sathiyaseelan T; Murikipudi S; Lancaster TM; Atkinson MA; Wasserfall CH; Yu L; Ragupathy R; Bonami RH; Zion TC Front Immunol; 2024; 15():1367514. PubMed ID: 38515750 [TBL] [Abstract][Full Text] [Related]
29. Do we really need to differentiate mesenchymal stem cells into insulin-producing cells for attenuation of the autoimmune responses in type 1 diabetes: immunoprophylactic effects of precursors to insulin-producing cells. Sharma A; Rani R Stem Cell Res Ther; 2017 Jul; 8(1):167. PubMed ID: 28701182 [TBL] [Abstract][Full Text] [Related]
30. Adverse effect on syngeneic islet transplantation by transgenic coexpression of decoy receptor 3 and heme oxygenase-1 in the islet of NOD mice. Huang SH; Lin GJ; Chien MW; Chu CH; Yu JC; Chen TW; Hueng DY; Liu YL; Sytwu HK Transplant Proc; 2013 Mar; 45(2):580-4. PubMed ID: 23267792 [TBL] [Abstract][Full Text] [Related]
32. A 20-Mb region of chromosome 4 controls TNF-alpha-mediated CD8+ T cell aggression toward beta cells in type 1 diabetes. Chamberlain G; Wållberg M; Rainbow D; Hunter K; Wicker LS; Green EA J Immunol; 2006 Oct; 177(8):5105-14. PubMed ID: 17015694 [TBL] [Abstract][Full Text] [Related]
33. Unexpected functional consequences of xenogeneic transgene expression in beta-cells of NOD mice. Leiter EH; Reifsnyder P; Driver J; Kamdar S; Choisy-Rossi C; Serreze DV; Hara M; Chervonsky A Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():14-22. PubMed ID: 17919174 [TBL] [Abstract][Full Text] [Related]
34. Replacing murine insulin 1 with human insulin protects NOD mice from diabetes. Elso CM; Scott NA; Mariana L; Masterman EI; Sutherland APR; Thomas HE; Mannering SI PLoS One; 2019; 14(12):e0225021. PubMed ID: 31821343 [TBL] [Abstract][Full Text] [Related]
35. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice. Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021 [TBL] [Abstract][Full Text] [Related]
36. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nakayama M; Abiru N; Moriyama H; Babaya N; Liu E; Miao D; Yu L; Wegmann DR; Hutton JC; Elliott JF; Eisenbarth GS Nature; 2005 May; 435(7039):220-3. PubMed ID: 15889095 [TBL] [Abstract][Full Text] [Related]
37. Resident macrophages of pancreatic islets have a seminal role in the initiation of autoimmune diabetes of NOD mice. Carrero JA; McCarthy DP; Ferris ST; Wan X; Hu H; Zinselmeyer BH; Vomund AN; Unanue ER Proc Natl Acad Sci U S A; 2017 Nov; 114(48):E10418-E10427. PubMed ID: 29133420 [TBL] [Abstract][Full Text] [Related]
38. Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model. Zhao Y; Guo C; Hwang D; Lin B; Dingeldein M; Mihailescu D; Sam S; Sidhwani S; Zhang Y; Jain S; Skidgel RA; Prabhakar BS; Mazzone T; Holterman MJ Biochem Biophys Res Commun; 2010 Sep; 399(4):629-36. PubMed ID: 20691153 [TBL] [Abstract][Full Text] [Related]
39. Tolerogenic Delivery of a Hybrid Insulin Peptide Markedly Prolongs Islet Graft Survival in the NOD Mouse. Jamison BL; DiLisio JE; Beard KS; Neef T; Bradley B; Goodman J; Gill RG; Miller SD; Baker RL; Haskins K Diabetes; 2022 Mar; 71(3):483-496. PubMed ID: 35007324 [TBL] [Abstract][Full Text] [Related]
40. Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout. Jasinski JM; Yu L; Nakayama M; Li MM; Lipes MA; Eisenbarth GS; Liu E Diabetes; 2006 Jul; 55(7):1978-84. PubMed ID: 16804066 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]